hummmmm,,,,,,,,,,,DM's comment to me seems more in line with the idea that 208 is none eventful when taking the drug,,as in side effects, safety etc and thus attractive to the trial patient,,, so all patients on both sides of the trial would certainly lean toward continuation,,,,,,it seems to be practical and good judgement to view possible life saving or extending solutions in this regard,,but thats just an opinion,,,hopefully the drug was taken by all participants this time,,,,being critical ill might be the self fullfilling circumstance that will have increased trial compliance by the patients,,,,,!